共 97 条
[1]
Jemal A(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96
[2]
Siegel R(2008)Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83 584-594
[3]
Ward E(2009)Current treatments for advanced stage non-small cell lung cancer Proc Am Thorac Soc 6 233-241
[4]
Molina JR(2002)Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92-98
[5]
Yang P(2002)The epidermal growth factor receptor: a new target for anticancer therapy Curr Probl Cancer 26 109-164
[6]
Cassivi SD(2008)Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments Clin Cancer Res 14 957-960
[7]
Stinchcombe TE(2008)Erlotinib-induced skin rash. Pathogenesis, clinical significance and management in pancreatic cancer patients Jop 9 267-274
[8]
Socinski MA(2009)Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer J Clin Oncol 27 5080-5087
[9]
Schiller JH(2005)TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer J Clin Oncol 23 5892-5899
[10]
Harrington D(1996)Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1-12